Category: Blood Diseases
Global Blood Diseases
-
Desmopressin
... of 5.5% over the analysis period 2023-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
2024-2029 World Anemia Diagnostic Testing Market Assessment in 100 Countries - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities
... and analysis not available from any other published source, including: Supplier Sales and Shares by Segment and Test Volume and Sales Segment Forecasts by Test Supplier Strategies and SWOT Analysis Instrumentation Pipeline Emerging Technologies Opportunities ... Read More
-
2024-2029 Global Anemia Diagnostic Testing Market Assessment in US, Europe, Japan - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities
... information and analysis not available from any other published source, including: Supplier Sales and Shares by Segment and Test Volume and Sales Segment Forecasts by Test Supplier Strategies and SWOT Analysis Instrumentation Pipeline Emerging Technologies ... Read More
-
Global Rare Hematology Market 2024-2028
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
2024 Blood & AutoImmune Diseases Global Market Size & Growth Report with Updated Analysis & Forecasts
... share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The historical data ... Read More
-
Hemophilia Drugs
... at a CAGR of 5.4% over the analysis period 2023-2030. Hemophilia A Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$21.3 Billion by the end ... Read More
-
Bleeding Disorders Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global bleeding disorders market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global bleeding ... Read More
-
Global Cell and Gene Therapy Market Size Study, by Therapy Type (Cell Therapy, Gene Therapy), by Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders, Others) and Regional Forecasts 2022-2032
... and Gene Therapy Market was valued at approximately USD 12.62 billion in 2023 and exhibiting a compound annual growth rate (CAGR) of 18.04% during the forecast period 2024-2032. Cell and gene therapy are advanced medical ... Read More
-
Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price (High, Mid, Low), Application (Anemia, Blood Cancer), End User (Hospital, CTL, Govt Lab, Blood Bank) - Global Forecast to 2029
... Forecast to 2029 The global hematology analyzers and reagents market is projected to reach USD 8.8 billion by 2029 from USD 6.6 billion in 2024, growing at a CAGR of 6.1% during the forecast period. ... Read More
-
Plasma Fractionation
... at a CAGR of 5.2% over the analysis period 2023-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$14.8 Billion by the end of the ... Read More
-
2024 Global Forecast for Sickle Cell Disease Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
Global Anti-thrombin III Testing Market 2024-2028
... forecast period. The report on the anti-thrombin III testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Rare Hemophilia Factors Market 2024-2028
... forecast period. The report on the rare hemophilia factors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Plasma Fractionation Market Research Report Data by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others), by Method (Cryoprecipitation, Chromatography, Ethanol Precipitation, Ultrafiltration, and Others), by Application (Immunology, Neurology, Hematology, Critical Care, Pulmonology, Rheumatology, Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Industry Forecast to 2030
... Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Industry Forecast to 2030 In 2023, the ... Read More
-
Drugs and Diagnostics for Hematological Disorders: Global Markets
... diseases. Based on product type, the diagnostic market for hematological disorders is divided into reagents & instruments and software. By end user, the market is segmented into hospitals, diagnostic labs, and others. On the basis ... Read More
-
Global Iron-Deficiency Anemia Therapy Market
... period of 2024 to 2031. Market Segmentation: Global Iron-Deficiency Anemia Therapy Market, By Therapy (Parenteral Iron Therapy and Oral Iron Therapy), Therapy Area (Obstetrics and Gynecology, Renal Diseases, Congestive Heart Failure (CHF), Oncology, Inflammatory Bowel ... Read More
-
Anemia Drugs
... at a CAGR of 4.1% over the analysis period 2023-2030. Iron Deficiency Anemia Drugs, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the ... Read More
-
Intravenous (IV) Iron Drugs
... reach US$4.8 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach ... Read More
-
Anticoagulants
... of 9.1% over the analysis period 2023-2030. NOACs Drug Class, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis ... Read More
-
2024 Global: Hemophilia Treatment Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Global Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028
... on the autoimmune hemolytic anemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Iron Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Sickle Cell Anemia Therapeutics Competitive Landscape Professional Research Report 2024
... a genetic disorder characterized by abnormal hemoglobin production. Therapeutic approaches for sickle cell anemia may include disease-modifying medications such as hydroxyurea, which increases fetal hemoglobin production and reduces the frequency of painful vaso-occlusive crises. Other ... Read More
-
Global Hemophilia Gene Therapy Competitive Landscape Professional Research Report 2024
... Typically, hemophilia gene therapy involves introducing a functional copy of the clotting factor gene into the patient＇s cells, often using viral vectors as delivery vehicles. The goal is to enable the patient＇s cells to produce ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
... 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030. Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized ... Read More
Research Assistance
